Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−6.00 EUR
−4.84 M EUR
0.00 EUR
30.11 M
About Oruka Therapeutics, Inc.
Sector
CEO
Lawrence O. Klein
Website
Headquarters
Menlo Park
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HQ1 is 20.20 EUR — it has increased by 4.66% in the past 24 hours. Watch ORUKA THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ORUKA THERAPEUTICS INC stocks are traded under the ticker HQ1.
HQ1 stock has risen by 6.32% compared to the previous week, the month change is a 2.02% rise, over the last year ORUKA THERAPEUTICS INC has showed a −7.34% decrease.
We've gathered analysts' opinions on ORUKA THERAPEUTICS INC future price: according to them, HQ1 price has a max estimate of 44.79 EUR and a min estimate of 36.56 EUR. Watch HQ1 chart and read a more detailed ORUKA THERAPEUTICS INC stock forecast: see what analysts think of ORUKA THERAPEUTICS INC and suggest that you do with its stocks.
HQ1 stock is 5.21% volatile and has beta coefficient of 0.18. Track ORUKA THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is ORUKA THERAPEUTICS INC there?
Today ORUKA THERAPEUTICS INC has the market capitalization of 709.73 M, it has decreased by −5.07% over the last week.
Yes, you can track ORUKA THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
ORUKA THERAPEUTICS INC is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
HQ1 earnings for the last quarter are −1.31 EUR per share, whereas the estimation was −0.36 EUR resulting in a −263.27% surprise. The estimated earnings for the next quarter are −0.66 EUR per share. See more details about ORUKA THERAPEUTICS INC earnings.
ORUKA THERAPEUTICS INC revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
HQ1 net income for the last quarter is −25.71 M EUR, while the quarter before that showed −2.50 M EUR of net income which accounts for −928.22% change. Track more ORUKA THERAPEUTICS INC financial stats to get the full picture.
As of Jan 4, 2025, the company has 5.00 employees. See our rating of the largest employees — is ORUKA THERAPEUTICS INC on this list?
Like other stocks, HQ1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORUKA THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.